LARIMAR THERAPEUTICS, INC. Increase (Decrease) in Accrued Liabilities
LARIMAR THERAPEUTICS, INC. (LRMR) reported Increase (Decrease) in Accrued Liabilities of -$33.16 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-04
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was -$12.76M, a 590.62% decline year-over-year.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$20.40M.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $25.76M, a 252.91% increase year-over-year.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $11.31M.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2025 was $37.55M, a 179.49% increase from fiscal 2024.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2024 was $13.44M.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2023 was -$1.02M, a 156.28% decline from fiscal 2022.
- LARIMAR THERAPEUTICS, INC. increase (decrease) in accrued liabilities for fiscal 2022 was $1.82M, a 142.46% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 3 month as first filed | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$12.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | -$33.16M 10-Q · filed 2026-08-04 | -$7.40M derived: sum of 3 quarters · filed 2026-08-04 | $3.92M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2026-03-31 | -$20.40M 10-Q · filed 2026-05-14 | $5.36M derived: sum of 2 quarters · filed 2026-05-14 | $16.67M derived: sum of 3 quarters · filed 2026-05-14 | $19.27M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-12-31 | $25.76M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $37.07M derived: sum of 2 quarters · filed 2026-03-19 | $39.67M derived: sum of 3 quarters · filed 2026-08-04 | $37.55M 10-K · filed 2026-03-19 | |
| 2025-09-30 | $11.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $13.91M derived: sum of 2 quarters · filed 2026-08-04 | $11.79M 10-Q · filed 2025-11-05 | $19.09M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-06-30 | $2.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $479.00K 10-Q · filed 2026-08-04 | $7.78M derived: sum of 3 quarters · filed 2026-08-04 | $4.15M derived: sum of 4 quarters · filed 2026-08-04 | |
| 2025-03-31 | -$2.12M 10-Q · filed 2026-05-14 | $5.18M derived: sum of 2 quarters · filed 2026-05-14 | $1.55M derived: sum of 3 quarters · filed 2026-05-14 | $8.65M derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $7.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $3.67M derived: sum of 2 quarters · filed 2026-03-19 | $10.77M derived: sum of 3 quarters · filed 2026-03-19 | $13.44M 10-K · filed 2026-03-19 | |
| 2024-09-30 | -$3.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.48M derived: sum of 2 quarters · filed 2025-11-05 | $6.14M 10-Q · filed 2025-11-05 | $8.43M derived: sum of 4 quarters · filed 2025-11-05 | |
| 2024-06-30 | $7.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $9.77M 10-Q · filed 2025-08-14 | $12.06M derived: sum of 3 quarters · filed 2025-08-14 | $12.79M derived: sum of 4 quarters · filed 2025-08-14 | |
| 2024-03-31 | $2.66M 10-Q · filed 2025-04-30 | $4.95M derived: sum of 2 quarters · filed 2025-04-30 | $5.68M derived: sum of 3 quarters · filed 2025-04-30 | $3.32M derived: sum of 4 quarters · filed 2025-04-30 | |
| 2023-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $3.02M derived: sum of 2 quarters · filed 2025-03-24 | $660.00K derived: sum of 3 quarters · filed 2025-03-24 | -$1.02M 10-K · filed 2025-03-24 | |
| 2023-09-30 | $729.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30 | -$1.63M derived: sum of 2 quarters · filed 2024-10-30 | -$3.31M 10-Q · filed 2024-10-30 | -$2.60M derived: sum of 4 quarters · filed 2024-10-30 | |
| 2023-06-30 | -$2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$4.04M 10-Q · filed 2024-08-08 | -$3.32M derived: sum of 3 quarters · filed 2024-08-08 | -$2.29M derived: sum of 4 quarters · filed 2024-08-08 | |
| 2023-03-31 | -$1.68M 10-Q · filed 2024-05-09 | -$963.00K derived: sum of 2 quarters · filed 2024-05-09 | $70.00K derived: sum of 3 quarters · filed 2024-05-09 | $886.00K derived: sum of 4 quarters · filed 2024-05-09 | |
| 2022-12-31 | $719.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $1.75M derived: sum of 2 quarters · filed 2024-03-14 | $2.57M derived: sum of 3 quarters · filed 2024-03-14 | $1.82M 10-K · filed 2024-03-14 | |
| 2022-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.85M derived: sum of 2 quarters · filed 2023-11-14 | $1.10M 10-Q · filed 2023-11-14 | -$277.00K derived: sum of 4 quarters · filed 2023-11-14 | |
| 2022-06-30 | $816.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | $64.00K 10-Q · filed 2023-08-10 | -$1.31M derived: sum of 3 quarters · filed 2023-08-10 | $981.00K derived: sum of 4 quarters · filed 2023-08-10 | |
| 2022-03-31 | -$752.00K 10-Q · filed 2023-05-15 | -$2.13M derived: sum of 2 quarters · filed 2023-05-15 | $165.00K derived: sum of 3 quarters · filed 2023-05-15 | $1.23M derived: sum of 4 quarters · filed 2023-05-15 | |
| 2021-12-31 | -$1.37M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $917.00K derived: sum of 2 quarters · filed 2023-03-14 | $1.98M derived: sum of 3 quarters · filed 2023-03-14 | $749.00K 10-K · filed 2023-03-14 | |
| 2021-09-30 | $2.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $3.35M derived: sum of 2 quarters · filed 2022-11-10 | $2.12M 10-Q · filed 2022-11-10 | $4.64M derived: sum of 4 quarters · filed 2022-11-10 | |
| 2021-06-30 | $1.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$168.00K 10-Q · filed 2022-08-11 | $2.35M derived: sum of 3 quarters · filed 2022-08-11 | $2.00M derived: sum of 4 quarters · filed 2022-08-11 | |
| 2021-03-31 | -$1.23M 10-Q · filed 2022-05-12 | $1.29M derived: sum of 2 quarters · filed 2022-05-12 | $933.00K derived: sum of 3 quarters · filed 2022-05-12 | $1.77M derived: sum of 4 quarters · filed 2022-05-12 | |
| 2020-12-31 | $2.52M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25 | $2.17M derived: sum of 2 quarters · filed 2022-03-25 | $3.00M derived: sum of 3 quarters · filed 2022-03-25 | $3.23M 10-K · filed 2022-03-25 | |
| 2020-09-30 | -$354.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $483.00K derived: sum of 2 quarters · filed 2021-11-12 | $713.00K 10-Q · filed 2021-11-12 | $43.00K derived: sum of 4 quarters · filed 2021-11-12 | |
| 2020-06-30 | $837.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | $1.07M 10-Q · filed 2021-08-12 | $397.00K derived: sum of 3 quarters · filed 2021-08-12 | $2.00M derived: sum of 4 quarters · filed 2021-08-12 | |
| 2020-03-31 | $230.00K 10-Q · filed 2021-05-10 | -$163.00K 10-Q · filed 2020-05-07 | -$440.00K derived: sum of 2 quarters · filed 2021-05-10 | $1.16M derived: sum of 3 quarters · filed 2021-05-10 | $2.29M derived: sum of 4 quarters · filed 2021-05-10 |
| 2019-12-31 | -$670.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | $934.00K derived: sum of 2 quarters · filed 2021-03-04 | $2.06M derived: sum of 3 quarters · filed 2021-03-04 | $945.00K 10-K · filed 2021-03-04 | |
| 2019-09-30 | $1.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $2.73M derived: sum of 2 quarters · filed 2020-11-12 | $1.61M 10-Q · filed 2020-11-12 | $1.14M derived: sum of 4 quarters · filed 2020-11-12 | |
| 2019-06-30 | $1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $11.00K 10-Q · filed 2020-08-14 | -$469.00K derived: sum of 3 quarters · filed 2020-08-14 | $226.00K derived: sum of 4 quarters · filed 2020-08-14 | |
| 2019-03-31 | -$1.12M 10-Q · filed 2020-05-07 | -$1.60M derived: sum of 2 quarters · filed 2020-05-07 | -$904.00K derived: sum of 3 quarters · filed 2020-05-07 | $36.00K derived: sum of 4 quarters · filed 2020-05-07 | |
| 2018-12-31 | -$480.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $215.00K derived: sum of 2 quarters · filed 2019-03-14 | $1.16M derived: sum of 3 quarters · filed 2019-03-14 | $628.00K 10-K · filed 2019-03-14 | |
| 2018-09-30 | $695.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | $1.64M derived: sum of 2 quarters · filed 2018-11-09 | $1.11M 10-Q · filed 2018-11-09 | $2.29M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2018-06-30 | $940.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $413.00K 10-Q · filed 2018-08-09 | $1.60M derived: sum of 3 quarters · filed 2019-03-14 | $1.99M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2018-03-31 | -$527.00K 10-Q · filed 2018-05-10 | $658.00K derived: sum of 2 quarters · filed 2019-03-14 | $1.05M derived: sum of 3 quarters · filed 2019-03-14 | -$84.00K derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-12-31 | $1.19M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $1.57M derived: sum of 2 quarters · filed 2019-03-14 | $443.00K derived: sum of 3 quarters · filed 2019-03-14 | $575.00K 10-K · filed 2019-03-14 | |
| 2017-09-30 | $388.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | -$742.00K derived: sum of 2 quarters · filed 2018-11-09 | -$610.00K 10-Q · filed 2018-11-09 | -$1.45M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-06-30 | -$1.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | -$998.00K 10-Q · filed 2018-08-09 | -$1.84M derived: sum of 3 quarters · filed 2019-03-14 | -$2.21M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2017-03-31 | $132.00K 10-Q · filed 2018-05-10 | -$711.00K derived: sum of 2 quarters · filed 2019-03-14 | -$1.08M derived: sum of 3 quarters · filed 2019-03-14 | -$2.82M derived: sum of 4 quarters · filed 2019-03-14 | |
| 2016-12-31 | -$843.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | -$1.22M derived: sum of 2 quarters · filed 2019-03-14 | -$2.95M derived: sum of 3 quarters · filed 2019-03-14 | -$2.25M 10-K · filed 2019-03-14 | |
| 2016-09-30 | -$372.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$2.11M derived: sum of 2 quarters · filed 2017-11-07 | -$1.41M 10-Q · filed 2017-11-07 | -$1.82M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-06-30 | -$1.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | -$1.04M 10-Q · filed 2017-08-09 | -$1.45M derived: sum of 3 quarters · filed 2018-03-09 | $711.00K derived: sum of 4 quarters · filed 2018-03-09 | |
| 2016-03-31 | $695.00K 10-Q · filed 2017-05-09 | $288.00K derived: sum of 2 quarters · filed 2018-03-09 | $2.44M derived: sum of 3 quarters · filed 2018-03-09 | $2.90M derived: sum of 4 quarters · filed 2018-03-09 | |
| 2015-12-31 | -$407.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $1.75M derived: sum of 2 quarters · filed 2018-03-09 | $2.20M derived: sum of 3 quarters · filed 2018-03-09 | $3.19M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $2.61M derived: sum of 2 quarters · filed 2016-11-09 | $3.60M 10-Q · filed 2016-11-09 | -$3.15M derived: sum of 4 quarters · filed 2017-03-10 | |
| 2015-06-30 | $452.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $1.44M 10-Q · filed 2016-08-05 | -$5.31M derived: sum of 3 quarters · filed 2017-03-10 | $2.98M derived: sum of 4 quarters · filed 2017-03-10 | |
| 2015-03-31 | $990.00K 10-Q · filed 2016-05-10 | -$5.76M derived: sum of 2 quarters · filed 2017-03-10 | $2.53M derived: sum of 3 quarters · filed 2017-03-10 | $2.97M derived: sum of 4 quarters · filed 2017-03-10 | |
| 2014-12-31 | -$6.75M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $1.54M derived: sum of 2 quarters · filed 2017-03-10 | $1.98M derived: sum of 3 quarters · filed 2017-03-10 | $2.33M 10-K · filed 2017-03-10 | |
| 2014-09-30 | $8.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 | $8.73M derived: sum of 2 quarters · filed 2015-11-13 | $9.08M 10-Q · filed 2015-11-13 | $8.45M derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-06-30 | $441.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-14 | $791.00K 10-Q · filed 2015-08-14 | $163.00K derived: sum of 3 quarters · filed 2016-03-15 | -$521.00K derived: sum of 4 quarters · filed 2016-03-15 | |
| 2014-03-31 | $350.00K 10-Q · filed 2015-05-14 | -$278.00K derived: sum of 2 quarters · filed 2016-03-15 | -$962.00K derived: sum of 3 quarters · filed 2016-03-15 | ||
| 2013-12-31 | -$628.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$1.31M derived: sum of 2 quarters · filed 2016-03-15 | -$799.00K 10-K · filed 2016-03-15 | ||
| 2013-09-30 | -$684.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$171.00K 10-Q · filed 2014-11-13 | |||
| 2013-06-30 | $513.00K 10-Q · filed 2014-08-14 | ||||
| 2012-12-31 | $234.00K 10-K · filed 2015-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Emergent BioSolutions Inc. (EBS) | United States | $0.347B | -2.43 |
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |